Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?

To improve cardiovascular outcomes, dyslipidemia in patients with diabetes needs to be treated. Thus, these patients are likely to take glimepiride and rosuvastatin concomitantly. Therefore, this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Drug Des Devel Ther
Auteurs principaux: Kim, Choon Ok, Oh, Eun Sil, Kim, Hohyun, Park, Min Soo
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330189/
https://ncbi.nlm.nih.gov/pubmed/28260863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S129586
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires